Cardiometabolic diseases, such as type 2 diabetes mellitus (DM) and cardiovascular
disease (CVD), are a great health concern. The strategies aimed to increase awareness and …

Type 2 diabetes mellitus (T2DM), currently an epidemic, is expected to disproportionately
affect developing countries in the coming decades [1]. Thus, primary prevention of T2DM is a …

Metabolic characterization of type 2 diabetes mellitus (T2DM) is crucial for the identification
of individuals at risk for developing diabetes and T2DM-related vascular complications as …

Cardiovascular disease (CD) and peripheral vascular disease (PVD) are leading causes of
mortality and morbidity in western countries and also responsible of a huge burden in terms …

Cardiovascular diseases (CVDs) are the leading cause of death worldwide, but their
molecular etiology remains poorly understood, in part because they develop slowly as a …

Numerous molecular screening strategies have recently been developed to measure the
chemical diversity of a population's biofluids with the ultimate aim to provide clinicians …

Metabolomics, which targets at the extensive characterization and quantitation of global
metabolites from both endogenous and exogenous sources, has emerged as a novel …

The need to facilitate the complex management of cardiometabolic diseases (CMD) has led
to the detection of many biomarkers, however, there are no clear explanations of their role in …

Metabolomics, the comprehensive measurement of low-molecular-weight molecules in
biological fluids used for metabolic phenotyping, has emerged as a promising tool to better …

Metabolomics is one of the most rapidly growing areas of contemporary science. Although
classic genetics aims to link variations in the DNA sequence directly to distinct phenotypes,“ …